These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6427492)

  • 21. [Ambulatory treatment without complications. A 1-year experience in distal deep-vein thrombosis].
    Svensson P; Lethagen S; Lindén E; Berntorp E
    Lakartidningen; 1994 Aug; 91(34):2950-2. PubMed ID: 7990537
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on the medical treatment of deep vein thrombosis.
    Schulman S
    Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.
    Hull RD; Raskob GE; Rosenbloom D; Pineo GF; Lerner RG; Gafni A; Trowbridge AA; Elliott CG; Green D; Feinglass J
    Arch Intern Med; 1997 Feb; 157(3):289-94. PubMed ID: 9040295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
    van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR
    Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction.
    Wray R; Maurer B; Shillingford J
    N Engl J Med; 1973 Apr; 288(16):815-7. PubMed ID: 4571525
    [No Abstract]   [Full Text] [Related]  

  • 26. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent deep venous thrombosis in pregnancy.
    Klein K; Pauker SG
    Med Decis Making; 1982; 2(2):249-51. PubMed ID: 7167051
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
    Berkowitz SD
    Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.
    Powers PJ; Gent M; Jay RM; Julian DH; Turpie AG; Levine M; Hirsh J
    Arch Intern Med; 1989 Apr; 149(4):771-4. PubMed ID: 2650646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal therapeutic level of heparin therapy in patients with venous thrombosis.
    Hull RD; Raskob GE; Rosenbloom D; Lemaire J; Pineo GF; Baylis B; Ginsberg JS; Panju AA; Brill-Edwards P; Brant R
    Arch Intern Med; 1992 Aug; 152(8):1589-95. PubMed ID: 1497392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of acute deep venous thrombosis.
    Satiani B
    Am Fam Physician; 1982 Apr; 25(4):103-9. PubMed ID: 7064760
    [No Abstract]   [Full Text] [Related]  

  • 32. Prolonged hospitalization because of inappropriate delay of warfarin therapy in deep venous thrombosis.
    Westblom TU; Marienfeld RD
    South Med J; 1985 Oct; 78(10):1164-7. PubMed ID: 4049032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calf deep venous thrombosis. A wolf in sheep's clothing?
    Philbrick JT; Becker DM
    Arch Intern Med; 1988 Oct; 148(10):2131-8. PubMed ID: 3052345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute venous thrombosis. Therapeutic choices for superficial and deep veins.
    Messmore HL; Bishop M; Wehrmacher WH
    Postgrad Med; 1991 May; 89(7):73-7. PubMed ID: 2031032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Standard heparin versus low-molecular-weight heparin].
    Lockner D
    Wien Med Wochenschr; 1999; 149(2-4):37-8. PubMed ID: 10378320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of venous thromboembolism.
    ten Cate JW; Koopman MM; Prins MH; Büller HR
    Thromb Haemost; 1995 Jul; 74(1):197-203. PubMed ID: 8578457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulant therapy.
    Coon WW
    Am J Surg; 1985 Oct; 150(4A):45-9. PubMed ID: 3901792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G; Prandoni P; Santamaria MG; Bagatella P; Iorio A; Bazzan M; Moia M; Guazzaloca G; Bertoldi A; Tomasi C; Scannapieco G; Ageno W;
    N Engl J Med; 2001 Jul; 345(3):165-9. PubMed ID: 11463010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.